Latest Investor Relations News

Cochlear Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 2.15 per share for the six months ending December 2025, payable in April 2026 across multiple currencies.

Atlas Arteria has announced an ordinary dividend of AUD 0.20 per security for the six months ending December 2025, payable in April 2026. The dividend is fully unfranked, reflecting foreign income components.

ADX Energy has responded to ASX inquiries about recent unusual trading activity, confirming no undisclosed information but highlighting a recent placement settlement as a possible factor.

EVE Health Group has increased its placement funding to $1.3 million, backed by a cornerstone investor with pharmaceutical expertise, advancing its reformulated drug programs targeting billion-dollar global markets.

Lachlan Star Limited has provided important clarifications on visible gold imagery from its New Waverley project, confirming high-grade assay results while cautioning on the qualitative nature of visual gold observations.

Qualitas Real Estate Income Fund (QRI) is set to initiate an on-market buy-back of up to 10% of its units starting April 2026, aiming to address perceived undervaluation and align with sector peers.

360 Capital Mortgage REIT has announced an on-market buy-back program for up to 544,337 ordinary units, set to run from March 2026 through March 2027. This move signals a strategic capital management initiative without requiring security holder approval.

Pinnacle Investment Management has updated its dividend announcement, confirming a fully franked ordinary dividend of 29 cents per share and setting the Dividend Reinvestment Plan price at AUD 14.61020.

Cann Group Limited has raised $750,000 through a convertible note agreement with Obsidian Global, aiming to strengthen its working capital and move towards EBITDA positivity.

Latitude Group Holdings is considering launching a new Capital Notes 2 offer, potentially allowing existing CN1 holders to reinvest. The offer will require applications through appointed Syndicate Brokers under updated regulatory rules.

Reliance Worldwide Corporation has announced an additional A$120 million on-market share buy-back, reinforcing its confidence in the company’s strategy and financial health.

Oneview Healthcare has successfully raised A$19 million through a two-tranche placement and launched a Security Purchase Plan to further strengthen its financial position and accelerate AI development.